共 16 条
[1]
[2]
[3]
Conditional Deletion of Murine Fgf23 : Interruption of the Normal Skeletal Responses to Phosphate Challenge and Rescue of Genetic Hypophosphatemia[J] Erica L Clinkenbeard;Taryn A Cass;Pu Ni;Julia M Hum;Teresita Bellido;Matthew R Allen;Kenneth E White Journal of Bone and Mineral Research 2016,
[4]
Circulating Sclerostin and Dickkopf-1 (DKK1) in Predialysis Chronic Kidney Disease (CKD): Relationship with Bone Density and Arterial Stiffness[J] S. Thambiah;R. Roplekar;P. Manghat;I. Fogelman;W. Fraser;D. Goldsmith;Geeta Hampson Calcified Tissue International 2012,
[5]
Erythropoietin stimulates bone formation; cell proliferation; and angiogenesis in a femoral segmental defect model in mice[J] Bone 2011,
[6]
Bone morphogenetic protein 7: A broad-spectrum growth factor with multiple target therapeutic potency[J] Cytokine and Growth Factor Reviews 2011,
[7]
Vitamin D metabolism; cartilage and bone fracture repair[J] René St-Arnaud;Roy Pascal Naja Molecular and Cellular Endocrinology 2011,
[8]
Effects of naringin on the proliferation and osteogenic differentiation of human bone mesenchymal stem cell[J] Peng-Zhang;Ke-rong Dai;Shi-gui Yan;Wei-qi Yan;Chao-Zhang;De-qiang Chen;Bo-Xu;Zhan-wang Xu European Journal of Pharmacology 2009,
[9]
Chronic kidney disease mineral and bone disorder in children[J] Katherine Wesseling;Sevcan Bakkaloglu;Isidro Salusky Pediatric Nephrology 2008,
[10]
Erythropoietin (EPO) — EPO-receptor signaling improves early endochondral ossification and mechanical strength in fracture healing[J] Joerg H. Holstein;Michael D. Menger;Claudia Scheuer;Christoph Meier;Ulf Culemann;Rainer J. Wirbel;Patric Garcia;Tim Pohlemann Life Sciences 2006,